No trials match your search ""

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

  Stanford is currently accepting patients for this trial.

• Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

  Stanford is currently accepting patients for this trial.

• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  Stanford is currently accepting patients for this trial.

• An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

  Stanford is currently accepting patients for this trial.

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

  Stanford is currently accepting patients for this trial.

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

  Stanford is currently accepting patients for this trial.

• A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

  Stanford is currently accepting patients for this trial.

• Study of Infigratinib in Combination With Tamoxifen or With Fulvestrant and Palbociclib in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

  Stanford is currently accepting patients for this trial.

• Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer

  Stanford is currently accepting patients for this trial.

• FNA Tumor Sampling for CD137 Modulation: A Pilot Study

  Stanford is currently accepting patients for this trial.

• Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

  Stanford is currently accepting patients for this trial.

• Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• Lymphedema Study for Arm or Leg Lymphedema

  Stanford is currently accepting patients for this trial.

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  Stanford is currently accepting patients for this trial.

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  Stanford is currently accepting patients for this trial.

• Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer, STAMP Study

  Stanford is currently accepting patients for this trial.

• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  Stanford is currently accepting patients for this trial.

• Assessment of Patient Experience During Treatment for Cancer

  Stanford is currently accepting patients for this trial.

• Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

  Stanford is currently accepting patients for this trial.

• Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  Stanford is currently accepting patients for this trial.

• A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  Stanford is currently accepting patients for this trial.

• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  Stanford is currently accepting patients for this trial.

• Phase 1 Study of SQ3370 in Patients With Advanced Solid Tumors

  Stanford is currently accepting patients for this trial.

• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

  Stanford is currently accepting patients for this trial.

• Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

  Stanford is currently accepting patients for this trial.

• Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

  Stanford is currently accepting patients for this trial.

• Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

  Stanford is currently accepting patients for this trial.

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.